References
- Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279(15): 1200–5
- American Medical Association. Drug response variation and dosing information. In: Drug evaluations annual 1993. Phila-dephia: Saunders, 1993: chap 2
- Clark WG, Brater DC, Johnson AR. Pharmacogenetics: the individual response to drugs. In: Goth A. Medical pharmacology. 12th ed. St Louis: Mosby, 1988: chap 6
- Wernicke JF, Dunlop SR, Dornseif BE, et al. Low-dose fluoxetine therapy for depression. Psychopharmacol Bull 1988; 24(1): 183–8
- Louie AK, Lewis TB, Lannon RA. Use of low-dose fluoxetine in major depression and panic disorder. J Clin Psychiatry 1993; 54(11): 435–8
- Pies RW. Dose-related sensory distortions with Zolpidem. (Letter) J Clin Psychiatry 1995; 56(1): 35–6
- Merlotti L, Roehrs T, Koshorek G, et al. The dose effects of Zolpidem on the sleep of healthy normals. J Clin Psychopharmacol 1989; 9(1): 9–14
- Boolell M, Gepi-Attee S, Gingell JC, et al. Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol 1996; 78(2): 257–61
- Brandon ML, Weiner M. Clinical studies of terfenadine in seasonal allergic rhinitis. Arzneimittelforschung 1982; 32(9a): 1204–5
- Food and Drug Administration. Postmarketing safety of sildenafil citrate (Viagra). Food and Drug Administration Web site. Available at: http://www.fda.gov/cder/consumerinfo/viagra/safety3.htm. Accessed June 28, 1999
- Goldstein I, Lue TF, Padma-Nathan H, et al, for the Sildenafil Study Group. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998; 338(20): 397–404
- Cohen JS, Insel PA. The Physicians' Desk Reference: problems and possible improvements. Arch Intern Med 1996; 156(13): 1375–80
- Durrigl T, Vitaus M, Pucar I, et al. Diclofenac sodium (Voltaren): results of a multi-centre comparative trial in adult- onset rheumatoid arthritis. J Int Med Res 1975; 3(3): 139–44
- Salkind MR, Silverstone T. A clinical and psychometric evaluation of flurazepam. Br J Clin Pharmacol 1975; 2(3): 223–6
- The Joint National Committee. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153(2): 154–83
- McEvoy GK, ed. American Hospital Formulary Service, Drug Information 1997. Bethesda: American Society of Hospital Pharmacists, 1997
- Rubinstein A, Lurie Y, Groskop 1, et al. Cholesterol-lowering effects of a 10 mg daily dose of lovastatin in patients with initial total cholesterol levels 200 to 240 mg/dl (5.18 to 6.21 mmol/liter). Am J Cardiol 1991; 68(11): 1123–6
- Cohen MM, Clark L, Armstrong L, et al. Reduction of aspirin-induced fecal blood loss with low-dose misoprostol tablets in man. Dig Dis Sci 1985; 30(7): 605–11
- Lauritsen K, Andersen BN, Havelund T, et al. Effect of 10 mg and 20 mg omeprazole daily on duodenal ulcer: double-blind comparative trial. Aliment Pharmacol Ther 1989; 3(1): 59–67
- Gibian T. Rational drug therapy in the elderly or how not to poison your elderly patients. Aust Fam Physician 1992; 21(12): 1755–60
- Everitt DE, Avorn J, Baker MW. Clinical decision-making in the evaluation and treatment of insomnia. Am J Med 1990; 89(3): 357–62
- Dutch study attempts to quantify sexual dysfunction profiles among SSRIs. Primary Psychiat 1997; 4(7): 22–3
- Nawrocki J, Weiss S, Davidson MH, et al. Reduction in LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler Thromb Vase Biol 1995; 15(5): 678–82
- Chalmers TM. Clinical experience with Ibuprofen in the treatment of rheumatoid arthritis. Ann Rheum Dis 1969; 28(5): 513–7
- Beck TM, Ciociola AA, Jones SE, et al. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy. Ann Intern Med 1993; 118(6): 407–13
- Jones PH, Farmer JA, Cressman MD, et al. Once-daily pravastatin in patients with primary hypercholesterolemia: a dose- response study. Clin Cardiol 1991; 14(2): 146–51
- Physicians' Desk Reference, 53d ed. Montvale, NJ: Medical Economics, 1999
- Saku K, Sasaki J, Arakawa K. Low- dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia. Clin Ther 1989; 11(2): 247–57
- Schatzberg AF, Dessain E, O'Neil P, et al. Recent studies on selective serotonergic antidepressants: trazodone, fluoxetine, and fluvoxamine. J Clin Psychopharmacol 1987, 7(6 Suppl): 44–9S